Loading...
XASXMVP
Market cap29mUSD
Jan 09, Last price  
0.43AUD
1D
1.18%
1Q
-4.44%
Jan 2017
-90.27%
Name

Medical Developments International Ltd

Chart & Performance

D1W1MN
XASX:MVP chart
P/E
—
P/S
1.46
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
6.06%
Rev. gr., 5y
9.69%
Revenues
33m
+2.51%
5,404,0006,605,0007,396,0009,219,0008,727,0008,296,00010,206,00011,313,00011,733,0009,370,00011,608,00015,471,00018,347,00017,461,00020,876,00022,535,00025,272,00021,943,00032,337,00033,149,000
Net income
-41m
L+630.83%
168,000797,0001,207,000891,000810,000879,0001,743,0002,704,0002,309,000875,0001,529,0001,569,0001,820,000243,0001,038,000379,000-12,565,000-12,407,000-5,609,000-40,992,000
CFO
-11m
L-34.65%
569,0001,152,0001,267,0001,228,0001,284,000003,198,000977,0001,295,0003,359,00012,067,0004,011,0001,790,00021,271,000601,000-8,808,000-10,722,000-16,495,000-10,780,000
Dividend
Mar 05, 20200.0275862069 AUD/sh
Earnings
Feb 26, 2025

Profile

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
URL
http://www.medicaldev.com/
IPO date
Dec 15, 2003
Employees
68
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
33,149
2.51%
32,337
47.37%
21,943
-13.17%
Cost of revenue
44,150
71,492
50,031
Unusual Expense (Income)
NOPBT
(11,001)
(39,155)
(28,088)
NOPBT Margin
Operating Taxes
8,066
(1,883)
(3,501)
Tax Rate
NOPAT
(19,067)
(37,272)
(24,587)
Net income
(40,992)
630.83%
(5,609)
-54.79%
(12,407)
-1.26%
Dividends
Dividend yield
Proceeds from repurchase of equity
(533)
26,632
354
BB yield
1.49%
-40.78%
-0.33%
Debt
Debt current
371
352
348
Long-term debt
4,201
4,416
4,930
Deferred revenue
1,637
1,899
21,607
Other long-term liabilities
309
8,516
369
Net debt
(5,163)
(16,085)
(11,312)
Cash flow
Cash from operating activities
(10,780)
(16,495)
(10,722)
CAPEX
(793)
(7,665)
(5,214)
Cash from investing activities
(3,169)
(7,665)
(5,214)
Cash from financing activities
(807)
28,063
142
FCF
(21,433)
(36,909)
(23,786)
Balance
Cash
9,735
24,661
20,398
Long term investments
(3,808)
(3,808)
Excess cash
8,078
19,236
15,493
Stockholders' equity
45,734
81,315
57,298
Invested Capital
41,888
66,881
66,594
ROIC
ROCE
EV
Common stock shares outstanding
88,602
84,274
72,427
Price
0.41
-47.74%
0.78
-46.92%
1.46
-67.56%
Market cap
35,884
-45.06%
65,313
-38.24%
105,744
-66.22%
EV
30,721
49,228
94,432
EBITDA
(7,607)
(36,042)
(25,143)
EV/EBITDA
Interest
86
95
103
Interest/NOPBT